Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norspan versus Tiparol Retard for chronic osteoarthritis pain
2006-003233-32Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Jul 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine and tramadol in osteoarthritis (OA) (2 arms), sponsored by Mundipharma. Primary endpoint: Box Scale-11 pain score change. Started Jul 2006; status: completed.
02
Drugs
buprenorphinetramadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-003233-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003233-32.